Brief: Acrux Says Its Sixth Generic Application Accepted By U.S. FDA For Review

Acrux

08/08/2022 02:16

Aug 8 (Reuters) - Acrux Ltd  ACR.AX :
    * ACRUX'S SIXTH GENERIC APPLICATION ACCEPTED BY U.S. FDA FOR
REVIEW
    * ABBREVIATED NEW DRUG APPLICATION APPLICATION TO FDA FOR
ACYCLOVIR CREAM, 5%

Source text for Eikon:  ID:nASX3Xm2Dx 
Further company coverage:  ACR.AX 

 ((Reuters.Briefs@thomsonreuters.com;))